0000921895-23-002396.txt : 20231026 0000921895-23-002396.hdr.sgml : 20231026 20231026163307 ACCESSION NUMBER: 0000921895-23-002396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231025 FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NATAN DAVID CENTRAL INDEX KEY: 0001253108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 231350593 MAIL ADDRESS: STREET 1: 11190 BISCAYNE BLVD CITY: MIAMI STATE: FL ZIP: 33181 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form413531002nat_10262023.xml OWNERSHIP DOCUMENT X0508 4 2023-10-25 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001253108 NATAN DAVID 11190 BISCAYNE BLVD MIAMI FL 33181 1 0 0 0 0 Common Stock 2023-10-25 4 A 0 16250 0 A 66250 D The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant. /s/ David Natan 2023-10-26